GEN Exclusives

More »

GEN News Highlights

More »
Jun 30, 2011

UCB and Harvard Establish Research Alliance to Develop Antibody Therapeutics

  • Belgium-based UCB has established a research alliance with Harvard University that ultimately aims to transfer promising academic drug development research into the commercial arena, primarily in the areas of central nervous system and immunology. UCB will input its antibody generation and medicinal chemistry expertise into the alliance, and provide up to $6 million in funding over two years to support specific research projects led by Harvard scientists.

    The first research project under the collaboration will focus on the development of antibodies against a target with potential applications in diseases including diabetes and metabolic disorders. The program will be headed by Gokhan S. Hotamisligil, M.D., chair of the department of genetics and complex diseases at Harvard School of Public Health.

    “Harvard’s world-class academic research is an excellent fit with UCB’s world-class antibody research and central nervous system pharmacology,” states Ismail Kola, president of UCB NewMedicines. "Both parties will learn from each other through the collaboration and a two-way exchange of ideas. Harvard will benefit from UCB’s strengths and industry experience in drug discovery and development, while Harvard’s exceptional research will complement UCB’s internal expertise.”

     


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Lab-Grown Vaginas

Which body part do you think will be successfully engineered in the lab next?